RECRUITINGINTERVENTIONAL
Systemic Lupus Erythematosus and Accelerated Aging
About This Trial
The study aims at evaluating the phenomena of immune system aging in patients with Systemic lupus erythematosus.
Who May Be Eligible (Plain English)
Who May Qualify:
- male or female;
- age between 18 and 60 years;
- Lupus patient : diagnosis of systemic lupus erythematosus according to ACR or SLICC criteria;
- being affiliated to health insurance;
- willing to participate and to sign willing to sign a consent form.
Who Should NOT Join This Trial:
- pregnant or breastfeeding women;
- persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* male or female;
* age between 18 and 60 years;
* Lupus patient : diagnosis of systemic lupus erythematosus according to ACR or SLICC criteria;
* being affiliated to health insurance;
* willing to participate and to sign informed consent.
Exclusion Criteria:
* pregnant or breastfeeding women;
* persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent
Treatments Being Tested
BIOLOGICAL
blood sample
48 ml whole blood for Peripheral blood mononuclear cell (PBMC) and serum isolation
BIOLOGICAL
blood sample
blood for Peripheral blood mononuclear cell (PBMC) and serum isolation
Locations (1)
CHU de Bordeaux - Médecine Interne et Immunologie Clinique
Bordeaux, France